Press

November 12, 2020

Smart Medication Container Included in GDF Product Catalog

Smart Medication Container Included in GDF Product Catalog https://www.thearcadygroup.com/wp-content/uploads/2020/11/Screen-Shot-2020-11-12-at-12.40.12-PM.png 565 362 The Arcady Group The Arcady Group https://www.thearcadygroup.com/wp-content/uploads/2020/11/Screen-Shot-2020-11-12-at-12.40.12-PM.png November 12, 2020 November 12, 2020

March 7, 2019

Medicines for All Institute Develops New, Cost-Saving Synthesis of Anti-HIV Drug Emtricitabine

Medicines for All Institute Develops New, Cost-Saving Synthesis of Anti-HIV Drug Emtricitabine https://www.thearcadygroup.com/wp-content/uploads/2020/07/TAG_MedicationAbstract_v1.jpg 2000 1500 The Arcady Group The Arcady Group https://www.thearcadygroup.com/wp-content/uploads/2020/07/TAG_MedicationAbstract_v1.jpg March 7, 2019 September 9, 2020

July 13, 2018

Arcady Group Awarded Grant to Continue TB Medication Adherence Initiatives

Arcady Group Awarded Grant to Continue TB Medication Adherence Initiatives https://www.thearcadygroup.com/wp-content/uploads/2020/06/TAG_ResourceImage_v9-scaled.jpg 2560 1707 The Arcady Group The Arcady Group https://www.thearcadygroup.com/wp-content/uploads/2020/06/TAG_ResourceImage_v9-scaled.jpg July 13, 2018 September 9, 2020

Press

Smart Medication Container Included in GDF Product Catalog

Medicines for All Institute Develops New, Cost-Saving Synthesis of Anti-HIV Drug Emtricitabine

Arcady Group Awarded Grant to Continue TB Medication Adherence Initiatives

Accelerating the availability and uptake
of life-saving technologies and medications for patients who need them most.

Navigation

Latest Resources

Stay Connected

Press

Smart Medication Container Included in GDF Product Catalog

Medicines for All Institute Develops New, Cost-Saving Synthesis of Anti-HIV Drug Emtricitabine

Arcady Group Awarded Grant to Continue TB Medication Adherence Initiatives

Accelerating the availability and uptake of life-saving technologies and medications for patients who need them most.

Accelerating the availability and uptake
of life-saving technologies and medications for patients who need them most.